- 2.
Report from the Danish Health and Medicines Authority for consideration by EMA and rapporteurs in relation to the assessment of the safety profile of HPV vaccines. http://sundhedsstyrelsen.dk/~/media/0A404AD71555435BB311CD59CB63071A.ashx (15.10.2016).
- 3.
European Medicines Agency. Assessment report. Human papillomavirus (HPV) vaccines. 11 November 2015. www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/HPV_vaccines_20/Opinion_provided_by_Committee_for_Medicinal_Products_for_Human_Use/WC500197129.pdf (15.10.2016).
- 4.
Brinth L, Theibel AC, Pors K et al. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J 2015; 62: A5064. [PubMed]
- 6.
Brinth L, Pors K, Hoppe AG et al. Is chronic fatigue syndrome/myalgic encephalomyelitis a relevant diagnosis in patients with suspected side effects to human papilloma virus vaccine? International Journal of Vaccines and Vaccination 2015; 1: 3 . [CrossRef]
- 7.
Danish Health and Medicines Authorities. EMA's new assessment of the HPV vaccine: The benefits outweigh the risks. 17 April 2015. https://sundhedsstyrelsen.dk/en/news/2015/emas-newassessment-of-the-hpv-vaccine-the-benefits-outweigh-the-risks (15.10.2016).
- 8.
European Medicines Agency. Briefing note to the experts. Confidential. 13 October 2015. EMA/666938/20 15. London: EMA, 2015.
- 9.
Gøtzsche PC, Jørgensen KJ, Jefferson T et al. Complaint to the European Medicines Agency (EMA) over maladministration at the EMA. 26 May 2016. http://nordic.cochrane.org/research-highlights (15.10.2016).
- 10.
Gøtzsche PC, Jørgensen KJ, Jefferson T et al. Complaint to the European ombudsman over maladministration at the European Medicines Agency (EMA) in relation to the safety of the HPV vaccines. 20 Oct 2016. http://nordic.cochrane.org/research-highlights (15.10.2016).
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.